![]() |
市场调查报告书
商品编码
1473932
全球微泡/超音波造影剂市场规模、份额、成长分析、按疾病领域(心血管疾病、肾臟疾病)、按应用(分子影像、药物传递)- 2024-2031 年产业预测Global Microbubbles/Ultrasound Contrast Agents Market Size, Share, Growth Analysis, By Disease Area(cardiovascular diseases, renal diseases), By Application(molecular imaging, drug delivery) - Industry Forecast 2024-2031 |
2022年全球微泡/超音波造影剂市场规模为18.7亿美元,预计将从2023年的19.4亿美元增长到2031年的26.6亿美元,在预测期内(2024-2031年)复合年增长率为4.00亿美元,在预测期内(2024-2031年)复合年增长率为4.00亿美元,在预测期内(2024-2031年)复合年增长率为4.00亿美元% 。
医学影像中用于增强 X 射线下液体或结构可视性的物质(称为造影剂或造影剂)通常对 X 射线是透明的。在对比超音波成像中,微泡在放射学和心臟病学中充当血池剂,在基因治疗、药物传输、分子成像和干细胞传输中广泛应用。这些微泡还可以透过与疾病特异性分子标记结合来发挥作用,提供一种有针对性的诊断手段。微泡的功能类似于静脉注射时循环中的红血球,在超音波脉衝下产生强烈的迴声,由于其与周围软组织气体的迴声不同,透过放大超音波反射或反向散射来增强超音波心动图的对比度。
Global Microbubbles/Ultrasound Contrast Agents Market size was valued at USD 1.87 billion in 2022 and is poised to grow from USD 1.94 billion in 2023 to USD 2.66 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).
A substance used in medical imaging to enhance the visibility of fluids or structures under X-rays, known as contrast media or contrast agent, is typically transparent to X-rays. In contrast ultrasound imaging, microbubbles serve as a blood pool agent in radiology and cardiology, finding extensive application in gene therapy, drug delivery, molecular imaging, and stem cell delivery. These microbubbles can also operate by binding to disease-specific molecular markers, offering a means of targeted diagnosis. Functioning akin to red blood cells in circulation upon intravenous injection, microbubbles generate strong echoes under ultrasound pulses, providing enhanced contrast in echocardiograms by amplifying ultrasound reflection or backscattering due to their differing echogenicity from surrounding soft tissue gases.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbubbles/Ultrasound Contrast Agents Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Microbubbles/Ultrasound Contrast Agents Market Segmental Analysis
Microbubbles/Ultrasound Contrast Agents market is segmented on the basis of disease area, By application, and By Region. Whereas, Disease area is sub segmented into cardiovascular diseases, renal diseases, and others. By Application is sub segmented into the molecular imaging, drug delivery, gene therapy, and stem cells delivery. By Region is segmented on the basis of North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.
Drivers of the Global Microbubbles/Ultrasound Contrast Agents Market
The utilization of microbubbles and ultrasound contrast agents in molecular imaging is increasingly fueled by the rising requirement for targeted therapies and the necessity to monitor biomarker status in vascular endothelium. Over the projected period, the market for microbubbles/ultrasound contrast agents is expected to grow, propelled by advancements in ultrasound technologies, escalating demand for targeted diagnostic instruments, the inherent advantages of microbubbles/ultrasound contrast agents compared to conventional diagnostic methods, and a surge in chronic disease prevalence.
Restraints in the Global Microbubbles/Ultrasound Contrast Agents Market
The global Microbubbles/Ultrasound Contrast Agents market faces a significant restraint due to the brief lifespan of microbubbles, hindering its growth prospects throughout the forecast period. Additionally, regulatory hurdles, limited reimbursement policies, and high manufacturing costs further impede market expansion, posing challenges to widespread adoption and innovation in ultrasound contrast agents.
Market Trends of the Global Microbubbles/Ultrasound Contrast Agents Market
In the fields of cardiology and radiology, microbubbles are employed as blood-pool agents in contrast ultrasound imaging but are increasingly acknowledged for their promise as targeted agents in molecular imaging. By incorporating ligand molecules that attach to disease-specific molecular markers, microbubbles can be tailored for functionality. This enables the monitoring of biomarker status in vascular endothelium, visualization of tumor vasculature, and imaging of inflammation, ischemia-reperfusion injury zones, and thrombi, presenting diverse clinical applications for molecular imaging utilizing microbubble-based ultrasound contrast agents.